All Posts By

Smartkarma Daily Briefs

Daily Brief Australia: AUB Group Limited, Seven West Media, ETFS FANG+ ETF, Pointerra Ltd, Pro Medicus Ltd and more

By | Australia, Daily Briefs

In today’s briefing:

  • Private Equity Consortium Eyes AUB Group Buyout Amid Insurance Brokerage Consolidation and Fair Valuation Offer
  • Seven West Media (SWM AU): Scheme Vote on 22 December
  • Primer: ETFS FANG+ ETF (FANG AU) – Nov 2025
  • Pointerra Ltd – Good cost containment in Q1 despite delays
  • Treasure Chest: Pro Medicus


Private Equity Consortium Eyes AUB Group Buyout Amid Insurance Brokerage Consolidation and Fair Valuation Offer

By Special Situation Investments

  • EQT’s A$45/share bid for AUB, with a 16% spread, follows a month of exclusive due diligence.
  • CVC Asia Pacific proposed forming a consortium with EQT, potentially increasing buyout success likelihood and financial commitment sharing.
  • AUB’s valuation metrics include 14.5x FY25 EBITDA and 26.2x P/E, with historical trading at lower multiples.

Seven West Media (SWM AU): Scheme Vote on 22 December

By Arun George

  • The Seven West Media (SWM AU) IE considers the SXL merger offer to be in the best interests of its shareholders, absent a superior proposal.
  • The merger requires approval from SWM shareholders, ACMA, and the ACCC. The ACCC’s findings will be announced on 18 December. 
  • The scheme vote is low risk as large SWM shareholders are supportive. Shares are trading through terms likely due to speculation of a competing bidder, which is unlikely to occur.  

Primer: ETFS FANG+ ETF (FANG AU) – Nov 2025

By αSK

  • The ETFS FANG+ ETF (FANG AU) offers concentrated exposure to 10 of the most highly-traded, technology-focused growth companies.
  • The underlying NYSE FANG+® Index is equally weighted, which differentiates it from market-cap-weighted technology indices and provides a more balanced exposure to its constituents.
  • While the ETF has demonstrated strong historical performance, its concentrated nature and focus on the volatile technology sector present a high-risk, high-reward investment proposition.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Pointerra Ltd – Good cost containment in Q1 despite delays

By Research as a Service (RaaS)

  • Pointerra Ltd (ASX:3DP) provides a powerful cloud-based solution (Pointerra3D) for managing, visualising, analysing, using and sharing massive 3D point clouds and geo-spatial datasets.
  • Pointerra3D is a proprietary digital twin Software-as-a-Service (SaaS) platform which delivers predictive digital insights and definitive answers to complex physical asset management questions.
  • Pointerra has reported Q1 FY26 cash receipts of $1.98m, down 36% on the previous corresponding period (pcp) but up 25% on Q4 FY25.

Treasure Chest: Pro Medicus

By FNArena

  • FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts.
  • Today’s idea is Pro Medicus.
  • Brokers reassess Pro Medicus after share price correction Quiet period offsets long-term growth momentum and contract wins AI, cloud certification, and flagship deployments strengthen outlook

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Singapore: Delfi Ltd, UOL Group, Lincotrade & Associates Holdings, SGX Rubber Future TSR20 and more

By | Daily Briefs, Singapore

In today’s briefing:

  • Delfi: 3rd Quarter Update Shows Positive Momentum
  • LONG UOL – The Rerating Imperative in Singapore Real Estate
  • Lincotrade & Associates Holdings – Strong FY25 Performance with Margin Expansion
  • India Tightens Trade Defences Across Rubber Spectrum


Delfi: 3rd Quarter Update Shows Positive Momentum

By Punit Khanna

  • Delfi announced 3rd qtr. update: Revenue increasing 4.9%. This is in contrast to1st Half when revenues were flat.
  • Revenue growth in Indonesia was driven by both pricing and volume gain in key brands in Indonesia & by regional markets
  • Indonesia sales would be higher at 6.9% on constant currency basis.

Raising Money for Persons with Disabilities in Singapore

For your kind consideration

This report has been prepared by Vriddhi Consulting, founded by Punit and Debjani Khanna. A portion of the research was contributed by Shubham Khanna, an individual on the autism spectrum.  We are grateful to Smartkarma for providing a platform to share this research and amplify its impact.

All proceeds from the publication of this report will be donated to support people with disabilities in Singapore. If you find this report valuable, we invite you to support our campaign, “Raising Money for Persons with Disabilities in Singapore.” Every contribution directly benefits the Goh Chok Tong Enable Fund and qualifies for a 250% tax deduction for Singapore tax residents.

To contribute, please visit this URL. 


LONG UOL – The Rerating Imperative in Singapore Real Estate

By Jacob Cheng

  • Macro Relief: The sharp decline in Singapore’s 3M SORA lowers financing costs and supports asset valuation through expected cap rate compression across the group’s diverse property portfolio.
  • Execution Premium: UOL has demonstrated best-in-class performance in the recovering residential segment, highlighted by rapid sales take-up in high-margin, prime-location projects, providing robust earnings visibility.
  • Financial Fortress: UOL operates with a conservative net gearing ratio that is unparalleled among major listed peers, providing the strategic capacity required for opportunistic land banking.

Lincotrade & Associates Holdings – Strong FY25 Performance with Margin Expansion

By SAC Capital

  • Lincotrade & Associates Holdings Limited is a Singapore-based interior fitting-out specialist with over 30 years of experience and an established track record in commercial, residential premises as well as showflats and sales galleries.
  • The Group was listed on the SGX Catalist board in August 2022 following a reverse takeover of Fabchem China.
  • Lincotrade is engaged in the provision of interior fitting-out services, additions and alterations (“A&A”) works and other building construction services.

India Tightens Trade Defences Across Rubber Spectrum

By Farah Miller

  • ADD Probe into Rubber Glove Imports from Malaysia, Thailand  
  • Finance Ministry imposes new duty on insoluble sulphur  
  • DGTR Recommends Continuation of Duties on NBR Imports  

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: SK Hynix, Korea Zinc, Classys, Soosan Industries and more

By | Daily Briefs, South Korea

In today’s briefing:

  • Hynix L2 Flag Risk: Why Stuck Below ₩620k? Eyes on Nov 17 Pivot
  • MBK Partners: Acquires Additional 2.7% Stake in Korea Zinc – Another M&A Fight in March 2026?
  • Primer: Classys (214150 KS) – Nov 2025
  • Primer: Soosan Industries (126720 KS) – Nov 2025


Hynix L2 Flag Risk: Why Stuck Below ₩620k? Eyes on Nov 17 Pivot

By Sanghyun Park

  • Hynix tagged L2: cash‑only, no margin. >40% two‑day rip triggers KRX halt. L2 caps distort tape; Square’s Oct 27–Nov 10 run showed the messy playbook.
  • Hynix L2 review: five >200% YoY prints since Nov 4, but no fresh 15‑day high—₩620k from Nov 3 still the cap, yesterday stalled just below.
  • Break above ₩620k likely triggers L2, leverage caps, volatile tape, Square outperformance; hold below into Monday kills L2 risk, keeps Hynix’s relative bid with retail still piling in.

MBK Partners: Acquires Additional 2.7% Stake in Korea Zinc – Another M&A Fight in March 2026?

By Douglas Kim

  • MBK Partners acquired an additional 2.7% stake in Korea Zinc raising its total ownership to 39.7%. This is likely to fuel additional positive share price momentum on Korea Zinc.
  • This is likely to rekindle a potential M&A fight for the management control of the company. 
  • This additional additional purchase of Korea Zinc by MBK Partners is a signal, not noise. Another M&A fight is likely in the next AGM in March 2026. 

Primer: Classys (214150 KS) – Nov 2025

By αSK

  • Classys is a high-growth medical aesthetics company poised for significant global expansion, driven by its flagship ‘Ultraformer’ (HIFU) and ‘Volnewmer’ (RF) product lines. The company’s growth strategy is centered on penetrating new, high-value markets such as the United States and Europe, supported by recent and anticipated regulatory approvals.
  • The business model, which combines initial equipment sales with recurring revenue from high-margin consumables, has delivered a robust financial profile characterized by strong revenue growth and impressive profitability. Consumables now account for a significant and growing portion of sales, providing a stable and predictable revenue stream.
  • Near-term challenges include potential margin compression due to shifts in product and geographic sales mix, as well as foreign exchange volatility. Long-term success is contingent on effective execution of its global expansion strategy, navigating intense competition, and maintaining its pace of innovation.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: Soosan Industries (126720 KS) – Nov 2025

By αSK

  • Soosan Industries is a key player in the South Korean power plant maintenance sector, specializing in essential services for the nation’s nuclear and thermal power generation facilities. The company is positioned to benefit from the government’s renewed focus on nuclear energy as a cornerstone of its long-term electricity supply plan.
  • The company exhibits attractive valuation metrics, with a low price-to-earnings and price-to-book ratio compared to the broader market. This, combined with a consistent dividend history, may appeal to value-oriented investors.
  • Recent financial performance indicates top-line pressure and margin contraction, reflecting potential cyclicality and a competitive operating environment. Future growth is heavily tied to securing new maintenance contracts and the execution of the national energy strategy, which includes both the extension of life for existing plants and the construction of new ones.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Groww, InterGlobe Aviation Ltd, Fractal Analytics Ltd, Alembic Ltd, Trent Ltd, KPIT Technologies, SGX Rubber Future TSR20 and more

By | Daily Briefs, India

In today’s briefing:

  • Groww IPO Trading – Decent Overall Demand
  • Quiddity Leaderboard BSE ​​​​SENSEX Dec25: Final Expectations; Announcement Soon
  • Fractal Analytics Pre-IPO: AI Play With Strong Fundamentals
  • Insider Activity: Who Bought Their Own Stock in October?
  • Trent Q2FY26: Growth Momentum Fades as Tier-II Mix Drags and Star Bazaar Slips
  • KPIT: Improving Trajectory, H2FY26 Guided to Be Significantly Better
  • India Tightens Trade Defences Across Rubber Spectrum


Groww IPO Trading – Decent Overall Demand

By Akshat Shah

  • Groww (1573648D IN) raised around US$747m in its India IPO. Groww, officially called Billionbrains Garage Ventures, is a direct-to-customer digital investment platform providing multiple financial products and services.
  • With Groww, customers can invest and trade in stocks (including via IPOs), derivatives, bonds, mutual funds and other products. Customers can also avail margin trading facility and personal loans.
  • We have looked at the company’s past performance and valuations in our previous notes. In this note, we will talk about the trading dynamics.

Quiddity Leaderboard BSE ​​​​SENSEX Dec25: Final Expectations; Announcement Soon

By Janaghan Jeyakumar, CFA

  • BSE SENSEX represents the 30 largest stocks listed in the Bombay Stock Exchange (BSE) of India.
  • In this insight, we have presented our final expectations for ADDs and DELs for the upcoming semiannual index rebal event in December 2025.
  • The official index changes could be announced publicly in the next few days.

Fractal Analytics Pre-IPO: AI Play With Strong Fundamentals

By Hong Jie Seow

  • Fractal Analytics Ltd (2453623D IN) is looking to raise US$560m in its upcoming India IPO.
  • Fractal Analytics Limited (FAL) is an enterprise AI company which supports large global enterprises with data-driven insights and assists them in their decision making through its end-to-end AI solutions.
  • In this note, we look at the company’s past performance.

Insider Activity: Who Bought Their Own Stock in October?

By Sreemant Dudhoria,CFA

  • We highlight large and small cap companies that experienced significant insider buying during October 2025, as reported on the stock exchanges.
  • October 2025 saw fewer companies reporting insider buying due to silent period before reporting their half yearly results.
  • Promoters of few companies had made the purchase in September but reported on exchanges in the month of October.

Trent Q2FY26: Growth Momentum Fades as Tier-II Mix Drags and Star Bazaar Slips

By Sudarshan Bhandari

  • Trent reported a 17% YoY rise in Q2FY26 revenue to INR 4,724 crore, while PAT grew 6%. Star Bazaar saw a 2% decline due to ongoing upgrades and stronger competition.
  • Efficient cost control and technology-driven productivity helped maintain margins despite slower same-store sales and expansion into lower-yield Tier-II cities.
  • Trent’s steady execution and well-diversified retail portfolio support its medium-term growth outlook, though high valuations and increasing operating costs remain key risks to monitor.

KPIT: Improving Trajectory, H2FY26 Guided to Be Significantly Better

By Ankit Agrawal, CFA

  • Despite macro challenges, KPIT delivered a decent Q2FY26 and is on track to post a much better H2FY26, led by reducing uncertainty and improving demand environment.
  • More importantly, KPIT has been adding select capabilities that have been pivotal to building its differentiation and competitiveness. Its approach to move to solutions vs services has been yielding fruition.
  • Deal wins came in strong in Q2FY26 at $232mm, well above the typical $150mm+ run-rate. Additionally, KPIT also won a mega $100mm+ deal.

India Tightens Trade Defences Across Rubber Spectrum

By Farah Miller

  • ADD Probe into Rubber Glove Imports from Malaysia, Thailand  
  • Finance Ministry imposes new duty on insoluble sulphur  
  • DGTR Recommends Continuation of Duties on NBR Imports  

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: Copper, Advanced Micro Devices, Atlassian , Quanta Services, Viomi Technology Co Ltd, Earth Science Tech, Health In Tech, L3Harris Technologies , Namib Minerals, Omega Healthcare Investors and more

By | Daily Briefs, United States

In today’s briefing:

  • Copper Finding Its Pulse in the Fog Of (Hitherto) Weak Demand
  • AMD in Q3 2025: Conviction in Bold Moves but a Rocky Road to Success
  • Atlassian’s Cloud + AI Combo Could Redefine How Companies Work Forever!
  • Quanta Services: Expansion into Power Generation, Renewable Energy Backlog Growth & Other Factors!
  • VIOT: Xiaomi relationship fuels exceptional first-half performance. Increasing our target valuation to 5.00/ADS.
  • ETST: F2Q26 Earnings – EPS as Expected Growth Set to Ramp Up
  • HIT: Strong 3Q & Outlook, With New Solutions Recently Introduced, Others Being Developed
  • L3Harris Technologies: An Insight Into Its Aerojet Rocketdyne’s Growth Trajectory…
  • NAMM: Production & Operational Update
  • Primer: Omega Healthcare Investors (OHI US) – Nov 2025


Copper Finding Its Pulse in the Fog Of (Hitherto) Weak Demand

By Raghav Vashisht

  • Global copper demand is stabilising after months of weakness, even as inventories thin out. The ICSG now expects a 150,000-ton deficit in 2026, reversing its earlier forecast of a surplus.
  • A softer dollar and expectations of continued Fed easing are improving the backdrop for commodities. The copper–gold ratio sits near 30-year lows, signalling room for mean reversion.
  • The bullish setup hinges on growth holding up and exceeding the rate of growth of China. Electrification to be the biggest driver.

AMD in Q3 2025: Conviction in Bold Moves but a Rocky Road to Success

By Raghav Vashisht

  • AMD achieved unprecedented revenue of $9.2 billion in Q3 2025, a 36% YoY growth driven despite margin contraction in the data centre segment.
  • Despite record data centre revenue of $4.3 billion, the uplift was carried by fifth-gen EPYC server CPUs rather than Instinct GPUs.
  • Multi-Year GPU commitments (from OpenAI to Oracle) strengthen the AI narrative without near-term numbers; Q4 guidance implies just 4% sequential growth, underscoring a digestion phase before the MI400 ramp.

Atlassian’s Cloud + AI Combo Could Redefine How Companies Work Forever!

By Baptista Research

  • Atlassian Corporation Plc reported strong financial performance for the first quarter of fiscal year 2026, achieving total revenue growth of 21% year-over-year, amounting to $1.4 billion.
  • A significant contributor to this growth was their cloud revenue, which saw a 26% increase to $998 million.
  • Additionally, the company’s remaining performance obligations (RPO) grew impressively by 42% to $3.3 billion.

Quanta Services: Expansion into Power Generation, Renewable Energy Backlog Growth & Other Factors!

By Baptista Research

  • Quanta Services has released their third quarter 2025 results reporting impressive figures with record growth in several financial metrics, including double-digit increases in revenue, adjusted EBITDA, and adjusted EPS compared to the previous year.
  • The company’s backlog reached a record $39.2 billion, indicating robust demand and a strong position going into 2026.
  • This growth can be attributed to heightened activity in their Electric segment and the broader infrastructural needs driven by the transformation within the energy sector.

VIOT: Xiaomi relationship fuels exceptional first-half performance. Increasing our target valuation to 5.00/ADS.

By Zacks Small Cap Research

  • Viomi preannounced in August that its first-half revenues would exceed RMB 1.4 billion ($195 million), and this week, the company published its complete income statement for the first six months, which demonstrated strong performance in the company’s core market.
  • We believe government policies in China drove a meaningful portion of the revenue growth in the first half.
  • We are not expecting that this program renews in 2026, but we will adjust our model if that changes.

ETST: F2Q26 Earnings – EPS as Expected Growth Set to Ramp Up

By Zacks Small Cap Research

  • Key F2Q26 takeaways include: 1) edging up our F2026 (Mar) EPS estimate by a penny to $0.02, while our F2027 forecast remains unchanged at $0.04, as a slightly flatter revenue growth trajectory is offset by more favorable margin assumptions 2) no change to our $1.00 price target suggesting meaningful upside potential from current levels, as ETST continues to trade at what we believe to be an unsustainably low valuation despite the company’s unique business model, compelling growth track record, improving profitability, and strong balance sheet and 3) balance sheet assets totaled $8.7 million, including cash of $1.2 million as of 9/30/25, up from $5.1 million a year ago, with net cash generated from operating activities of $1.2 million for the first six months of F2026.

HIT: Strong 3Q & Outlook, With New Solutions Recently Introduced, Others Being Developed

By Zacks Small Cap Research

  • HIT recently introduced a key expansion of its Do-It-Yourself Benefit System (eDIYBS) to extend capabilities to employers with 150 or more & is extremely encouraged about the prospects.
  • HIT also is testing a 3-year rate hold solution – expected to launch in 1Q26 – that it expects to boost customer retention and provide additional offerings for its distribution partners, and with JV partner AlphaTON Capital plans to jointly develop a blockchain-enabled healthcare insurance claims processing platform, HITChain, to address inefficiency and fraud in the domestic healthcare: claims processing space, lower administrative costs and improve transparency.

L3Harris Technologies: An Insight Into Its Aerojet Rocketdyne’s Growth Trajectory…

By Baptista Research

  • L3Harris Technologies reported positive financial results in its third quarter of 2025, highlighting both significant opportunities and challenges.
  • The company reported revenue of $5.7 billion, reflecting strong organic growth of 10% across its four segments, marking its position as a formidable player in the defense sector.
  • This growth was attributed largely to increased volume on existing programs, new program ramps, and heightened international demand, with the company noting a book-to-bill ratio of 1.2, indicating a healthy pipeline.

NAMM: Production & Operational Update

By Atrium Research

  • Namib Minerals outlined operational guidance for 2025, targeting 24-25Koz of gold and adjusted EBITDA of $22-26M, while focusing on grade optimization and throughput improvement at its How Mine.
  • Management outlined a phased restart plan for Redwing and Mazowe, with early-stage dewatering and infrastructure upgrades set to begin.
  • We initiated coverage on NAMM (see here), highlighting its strong growth potential as it advances two restart projects.

Primer: Omega Healthcare Investors (OHI US) – Nov 2025

By αSK

  • Omega Healthcare Investors is a leading real estate investment trust (REIT) specializing in skilled nursing facilities (SNFs), positioned to benefit from powerful long-term demographic tailwinds of an aging population.
  • The company’s triple-net lease model is designed to provide stable, predictable cash flows, supporting a historically strong dividend. However, this model’s success is heavily reliant on the financial health and operational stability of its tenant operators.
  • Key risks to the investment thesis include the significant dependence on government reimbursement policies (Medicare and Medicaid), which are subject to change, and the persistent operational challenges faced by SNF operators, such as rising labor costs and staffing shortages.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Qinghai Huzhu Barley Wine Co, Sungrow Power Supply, Verisilicon Microelectronics S, Tencent Music, First Pacific Co, Viomi Technology Co Ltd, Geely Auto, Shenzhen Zhaowei Machinery, EpimAb Biotherapeutics, Shenzhen Edge Medical and more

By | China, Daily Briefs

In today’s briefing:

  • CSI Liquor/ Alcoholic Drink Index Rebalance Preview: One Delete & Some Big Capping Changes
  • China A50 ETFs Rebalance Preview: Three Changes in December
  • CNI Semiconductor Chips Index Rebalance Preview: One Set of Changes in December
  • Tencent Music (TME): 3Q25, Offline Rev Up by 50%, Margin Improved for 13 Quarters
  • First Pacific (142 HK)’s Full Value As Maynilad Commences Trading
  • VIOT: Xiaomi relationship fuels exceptional first-half performance. Increasing our target valuation to 5.00/ADS.
  • Geely Automobile Holdings Ltd (0175 HK): Why Geely Is Actually a Bank
  • Shenzhen Zhaowei A/H Listing – Autos Thriving but Robotics Driving Share Price
  • Pre-IPO EpimAb Biotherapeutics – The TCE Pipeline Has Great Potential
  • Primer: Shenzhen Edge Medical (SEM HK) – Nov 2025


CSI Liquor/ Alcoholic Drink Index Rebalance Preview: One Delete & Some Big Capping Changes

By Brian Freitas

  • The review period ended on 31 October, the changes should be announced on 28 November and will be effective after the close of trading on 12 December.
  • There could be one delete each for the CSI Liquor Index and the CSI Alcoholic Drink Index. Plus capping changes for a bunch of stocks.
  • The entire sector has been under pressure over the last few years with every rally being sold into.

China A50 ETFs Rebalance Preview: Three Changes in December

By Brian Freitas


CNI Semiconductor Chips Index Rebalance Preview: One Set of Changes in December

By Brian Freitas


Tencent Music (TME): 3Q25, Offline Rev Up by 50%, Margin Improved for 13 Quarters

By Ming Lu

  • Total revenue grew by 21% YoY and offline revenue grew by 50% YoY in 3Q25.
  • Both ARPPU and the user base increased YoY in 3Q25.
  • The margin had improved year over year for 13 quarters.

First Pacific (142 HK)’s Full Value As Maynilad Commences Trading

By David Blennerhassett

  • The proposed spin-off – from 49.9%-held MPIC – and listing of Maynilad Water Services (MYNLD PH) completed on the 7th November. 
  • Priced at PHP 15/share, Maynilad closed yesterday at PHP 14.82/share, down 1.2%. 
  • First Pacific Co (142 HK)‘s indirect/direct holding in Maynilad is estimated at 19.1%, accounting for ~6% of NAV. 

VIOT: Xiaomi relationship fuels exceptional first-half performance. Increasing our target valuation to 5.00/ADS.

By Zacks Small Cap Research

  • Viomi preannounced in August that its first-half revenues would exceed RMB 1.4 billion ($195 million), and this week, the company published its complete income statement for the first six months, which demonstrated strong performance in the company’s core market.
  • We believe government policies in China drove a meaningful portion of the revenue growth in the first half.
  • We are not expecting that this program renews in 2026, but we will adjust our model if that changes.

Geely Automobile Holdings Ltd (0175 HK): Why Geely Is Actually a Bank

By J Capital Research

  • We believe that Geely Automobile, listed in Hong Kong as 0175, is a private equity fund first and an auto company second.

  • Expectations that Geely will become an international blockbuster akin to Toyota or Hyundai are misplaced.

  • Geely relied in 2024 for half its profit on mark-to-market value in subsidiaries.


Shenzhen Zhaowei A/H Listing – Autos Thriving but Robotics Driving Share Price

By Sumeet Singh

  • Shenzhen Zhaowei Machinery & Electronics (003021 CH), aims to raise around US$700m in its H-share listing.
  • Shenzhen Zhaowei Machinery & Electronic (SZME) is a provider of integrated micro transmission and drive system solutions ranking first in China and fourth globally by revenue, according to F&S.
  • In this note, we look at its past performance and other deal dynamics that might impact the listing.

Pre-IPO EpimAb Biotherapeutics – The TCE Pipeline Has Great Potential

By Xinyao (Criss) Wang

  • TCE has been highly popular for hematological malignancies and autoimmune diseases.Due to the “Fear of Missing Out” mentality, MNCs directly have purchased TCE assets or the Newco model is adopted.
  • Current clinical data is good for CRC, providing EMB-01 with a solid foundation for entering phase III trials.EMB-06 may face challenges in commercialization. EMB-07 has high hopes to be out-licensed.
  • Short-Term valuation could be lower than Akeso. Based on our forecast of the peak sales of EMB-01, EMB-06, EMB-07, long-term valuation could reach about US$16.5 billion.

Primer: Shenzhen Edge Medical (SEM HK) – Nov 2025

By αSK

  • Shenzhen Edge Medical is a leading Chinese surgical robotics company, notable for being the first in China and second globally to have multi-port, single-port, and bronchoscopy surgical robots approved for market launch.
  • The company is strategically positioned to capitalize on the rapidly growing but under-penetrated surgical robotics market in China, which is supported by strong government initiatives and increasing healthcare demand.
  • Despite its technological advancements and strong investor backing, the company is in its pre-revenue stage, facing significant net losses due to high R&D expenditure and intense competition from both domestic and international players.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Japan: Paris Miki Holdings, Human Made, Star Micronics, Softbank Group, JX Advanced Metals, Kyokuto Kaihatsu Kogyo Co, ASICS Corp and more

By | Daily Briefs, Japan

In today’s briefing:

  • [Japan M&A] Paris Miki Is Indeed an MBO Target; Luxottica May Complain But Tough To Block
  • Paris Miki (7455 JP): Chairman-Led MBO Likely Done Despite Luxottica’s Unclear Intentions
  • Human Made Pre-IPO: A Bathing Ape, Reborn
  • Star Micronics (7718 JP): Taiyo Pacific’s Tender Offer at JPY2,210
  • [Japan M&A] Taiyo Pacific Offers ¥2,210 for Star Micronics (7718) Completing the Shareholder Ripoff
  • Softbank Group (9984 JP): 1H FY03/26 flash update
  • SoftBank (9984 JP) Tactical Outlook: What’s Next After NVDA Exit, Wild Swings, and Strong Earnings?
  • JX Advanced Metals (5016 JP) — Second Guidance Upgrade; Margin Expansion Accelerates
  • Kyokuto Kaihatsu Kogyo Co (7226 JP): 1H FY03/26 flash update
  • Asics (7936) | Sustained Growth Momentum with Margin Upside


[Japan M&A] Paris Miki Is Indeed an MBO Target; Luxottica May Complain But Tough To Block

By Travis Lundy

  • Today after the close, Paris Miki Holdings (7455 JP) announced the Tane family Holdco would buy out the company in an “MBO” at ¥581, or 4.8x current year EBITDA. 
  • World famous eyeglass/sunglass manufacturer Luxottica bought 13.8% of the company in the low ¥300s almost stopping about a year ago. They might complain, but Paris Miki is a big outlet.
  • This looks like it gets done. The family+crossholders+ESOP+warrants have 65% of the expanded share count. Those who would complain would need to do so soon, and loudly.

Paris Miki (7455 JP): Chairman-Led MBO Likely Done Despite Luxottica’s Unclear Intentions

By Arun George

  • Paris Miki Holdings (7455 JP) has recommended a Chairman-led MBO at JPY581, a 48.6% premium to the last close price.
  • While the offer is arguably light as it is marginally below book value (P/B of 0.99x), it is above the midpoint of the IFA DCF valuation range. 
  • The offer represents a 10-year high. Luxottica Group (LUX IM), the second-largest shareholder, has not signalled whether it will tender, but it would struggle to derail the offer.

Human Made Pre-IPO: A Bathing Ape, Reborn

By Hong Jie Seow

  • Human Made (456A JP) aims to raise around US$116m in its Japan IPO.
  • Human Made Inc. is a Japan-based apparel and lifestyle company. Its business model centers on producing high-value, limited-supply apparel and goods.
  • In this note, we look at the company’s past performance.

Star Micronics (7718 JP): Taiyo Pacific’s Tender Offer at JPY2,210

By Arun George

  • Star Micronics (7718 JP) has recommended a tender offer from Taiyo Pacific Partners at JPY2,210, a 29.1% premium to the last close price.
  • The offer is arguably light as it is marginally above book value (P/B of 1.09x) and 16% below the midpoint of the target IFA DCF valuation range. 
  • However, the offer is attractive as it represents an all-time high and is 42.4% above Taiyo’s placement price in May 2025. Unless an activist emerges, this is likely done.  

[Japan M&A] Taiyo Pacific Offers ¥2,210 for Star Micronics (7718) Completing the Shareholder Ripoff

By Travis Lundy

  • Today after the close, well-known Japan engagement fund Taiyo Pacific Partners announced a deal to buy Star Micronics (7718 JP) for ¥2,210/share. They’ve been involved small-big-small for 20yrs.
  • The company launched a new capital plan and MTMP in February. Cash-rich, it needed no money to grow aggressively. So TPP proposed buying a third of the company. Board agreed.
  • Despite ActionsToImplementManagementConsciousOfSharePriceAndCostOfCapital announced February, in April-November the Board decided to sell the entire company to TPP at <1x book. This is borderline outrageous. It deserves notice and complaint.

Softbank Group (9984 JP): 1H FY03/26 flash update

By Shared Research

  • Revenue was JPY3,736.8bn (+7.7% YoY), with net income attributable to owners at JPY2,924.1bn (+190.9% YoY).
  • Investment gain was JPY3,926.7bn, including JPY2,156.7bn from OpenAI, with SVF business gaining JPY3,415.5bn.
  • Arm segment revenue reached JPY320.3bn (+17.0% YoY), with segment profit increasing 518.4% YoY to JPY23.6bn.

SoftBank (9984 JP) Tactical Outlook: What’s Next After NVDA Exit, Wild Swings, and Strong Earnings?

By Nico Rosti

  • Softbank Group (9984 JP) is swinging wildly. On Nov 11, the stock sank -13% after it said it had sold its entire stake in NVIDIA (NVDA US)  for $5.83 billion.
  • The stock also posted record Q2 earnings on Nov 12, but closed the day down -3.46% (after a strong rally from the 21k bottom). Most gains come from OpenAI investment.
  • For sure it’s not easy to hold this stock at the moment, this insight will analyze the next 2-3 weeks’ outlook, support and resistance, according to our quantitative model.

JX Advanced Metals (5016 JP) — Second Guidance Upgrade; Margin Expansion Accelerates

By Rahul Jain

  • JX Advanced Metals (5016 JP) — Second Guidance Upgrade; Margin Expansion Accelerates, Momentum Builds
  • Focus businesses now contribute nearly half of operating profit, reinforcing structural earnings quality.
  • JX Advanced Metals trades at ~22× FY26E P/E and ~13× EV/EBITDA, reflecting premium growth exposure but still below Japanese specialty materials peers (Tokyo Ohka ~26×, Entegris ~45×).

Kyokuto Kaihatsu Kogyo Co (7226 JP): 1H FY03/26 flash update

By Shared Research

  • Revenue increased by 15.9% YoY to JPY74.2bn, with all segments showing revenue growth and operating profit up 35.1% YoY.
  • Extraordinary loss of JPY5.9bn related to the Antimonopoly Act led to a net loss of JPY1.5bn.
  • Domestic demand remained firm, with revenue and profit rising YoY due to product price revisions and improved productivity.

Asics (7936) | Sustained Growth Momentum with Margin Upside

By Mark Chadwick

  • 7th straight quarter of double-digit growth; 3Q revenue +21% y/y to ¥222bn, led by strong EU and Japan performance and steady global expansion.
  • Gross margin +110bps to 56.1%, operating margin +320bps to 20.9%; FY OP guidance raised to ¥140bn, share buyback of ¥30bn announced.
  • Near-Term share impact limited, but long-term growth underpinned by SportStyle and Onitsuka Tiger; OP could double to ~¥260bn though next MTP cycle.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Quantitative Analysis: JPX Margin Trading Weekly (Nov 7th): SoftBank and more

By | Daily Briefs, Quantitative Analysis

In today’s briefing:

  • JPX Margin Trading Weekly (Nov 7th): SoftBank, Advantest, Fujikura, Sanrio, Socionext
  • KRX Short Interest Weekly (Nov 7th): NAVER, SAMSUNG SDS, L&F, Samsung SDI, Alteogen


JPX Margin Trading Weekly (Nov 7th): SoftBank, Advantest, Fujikura, Sanrio, Socionext

By Ke Yan, CFA, FRM

  • We analyzed the changes in margin trading positions of JPX stocks as of Nov 7th. The aggregated net margin trading position is USD20,487m.
  • We tabulate league tables for top/bottom net long/short of margin trading by value, net margin buy as multiple of ADT.
  • We highlight net margin buy/sell changes in SoftBank, Advantest, Fujikura, Sanrio, Socionext, Mitsubishi Heavy Industries, Nintendo, Recruit, IHI, Nippon Telegraph and Telephone, Softbank, Advantest, Fujikura, Sanrio, Socionext.

KRX Short Interest Weekly (Nov 7th): NAVER, SAMSUNG SDS, L&F, Samsung SDI, Alteogen

By Ke Yan, CFA, FRM

  • We analyzed the changes in short interest of KRX stocks as of Nov 7th. The aggregated short interest was USD11.9bn.
  • We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases & decreases in short value, short as multiple of ADT.
  • We highlight short interest changes in NAVER, SAMSUNG SDS, L&F, Samsung SDI, Alteogen.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thematic (Sector/Industry): Ohayo Japan | Softbank Sells Nvidia and more

By | Daily Briefs, Thematic (Sector/Industry)

In today’s briefing:

  • Ohayo Japan | Softbank Sells Nvidia
  • Japan Morning Connection: Softbank Numbers Smash Estimates, but Selling NVDA Sours Market Overall
  • Singapore Market Roundup (11-Nov-2025): Genting Singapore: Buy rating; DBS maintains Hold.
  • Asia Real Estate Tracker (11-Nov-2025): Weave acquires Tokyo apartments, reaching 1,400 units.
  • Briefing. Constellation Software’s Largest Ever Drawdown, Amazon’s AI Agent Risk, Copart & Floor …


Ohayo Japan | Softbank Sells Nvidia

By Mark Chadwick

  • The Dow hit a record high as investors rotated into value and blue-chip stocks, while the S&P 500 edged higher and the Nasdaq slipped modestly.
  • AI stocks slid after CoreWeave’s weak guidance, SoftBank exited Nvidia to fund OpenAI, and Michael Burry alleged accounting-driven profit inflation across major tech firms.
  • SoftBank posted record H1 FY25 profit of ¥2.92tn, driven by Vision Fund and OpenAI gains, boosting NAV to ¥36.2tn; sold Nvidia stake and announced a 1:4 share split.

Japan Morning Connection: Softbank Numbers Smash Estimates, but Selling NVDA Sours Market Overall

By Andrew Jackson

  • Bullish growth estimates from AMD will help alleviate negativity to start.
  • Yesterday saw some disappointing SPE/semi results from Kokusai Elec, Sumco and JX Advanced metals.
  • Sony surprised to the upside with a flurry of analysts weighing in with TP hikes overnight.

Singapore Market Roundup (11-Nov-2025): Genting Singapore: Buy rating; DBS maintains Hold.

By Singapore Market Roundup

  • ‘Buy’ calls for Genting Singapore; DBS keeps ‘hold’ rating.
  • Lim & Tan starts ‘buy’ on Zixin Group, targeting a price of 6.6 cents.
  • Maybank raises Sanli Environmental’s target price after $205M PUB project win.

Asia Real Estate Tracker (11-Nov-2025): Weave acquires Tokyo apartments, reaching 1,400 units.

By Asia Real Estate Tracker

  • Weave has significantly expanded its portfolio to 1,400 units through the acquisition of apartments in Tokyo.
  • AB Capital has enhanced its presence in Japan by acquiring properties in Osaka and securing a deal with Marriott.
  • Savills has appointed Neil Brookes, previously of Knight Frank, to lead its APAC Capital Markets division.

Briefing. Constellation Software’s Largest Ever Drawdown, Amazon’s AI Agent Risk, Copart & Floor …

By The Synopsis

  • US markets experienced declines, particularly in high growth sectors, amid fears of a potential AI bubble
  • Constellation Software’s stock drawdown may be attributed to investor fears of increased competition from AI, but the company’s strong customer relationships and focus on solving customer problems suggest they may not be as vulnerable as perceived

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Event-Driven: [Quiddity Index] Light & Wonder (LNW US/AU) US Delisting Event – Updating The Assumptions/Estimates and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • [Quiddity Index] Light & Wonder (LNW US/AU) US Delisting Event – Updating The Assumptions/Estimates
  • On China Shengmu (1432)’s Conditional MGO
  • ChiNext/​​​ChiNext50 Index Rebalance Preview: Maxing Out the Changes
  • China Shengmu (1432 HK): Possible Offer, Potentially Problematic 50% Min Acceptance Condition
  • Strategic Reviews, Mergers, and Financing Updates: Key Developments in Biopharma, Hospitality
  • Permira’s Recommended Cash Offer for JTC Plc
  • TrueCar’s Acquisition by Fair Holdings: Potential Returns, Funding Challenges


[Quiddity Index] Light & Wonder (LNW US/AU) US Delisting Event – Updating The Assumptions/Estimates

By Travis Lundy

  • Light & Wonder (LNW US) will be delisted at the close of tomorrow US time (two trading days left) and shares converted to Australian CDIs.
  • After studying the matter we have amended our assumptions on how flows work. More net selling than expected in November, irksome uncertainy in December, more buyback flows in the meantime.
  • The stock was higher on earnings in Australia, skipped a day, then skipped another day, then jumped in the US yesterday. 

On China Shengmu (1432)’s Conditional MGO

By David Blennerhassett

  • On the 30th October, China Modern Dairy (1117 HK) (CMD) entered into a conditional SPA to acquire a 1.28% stake in raw milk producer China Shengmu Organic Milk (1432 HK) (CSM). 
  • CMD currently holds 29.99% in CSM. Should the SPA complete, CMD clears 30% and will be obligated to make an Offer for all shares not held. 
  • The Offer Price will be A$0.35/share, a 14.75% premium to undisturbed. The Offer will be conditional on a 50% acceptance hurdle. 

ChiNext/​​​ChiNext50 Index Rebalance Preview: Maxing Out the Changes

By Brian Freitas

  • With the review period complete, we forecast 10 changes for the ChiNext Index (SZ399006 INDEX) and 5 changes for the ChiNext 50 Index in December.
  • The largest flows will be in 2 stocks that are forecast adds for both indices. There are 14 stocks with over 0.5x ADV to trade from passive trackers.
  • The forecast adds outperformed the forecast deletes from June to August, but there has been significant underperformance since then. Outperformance could resume as positioning kicks in prior to announcement.

China Shengmu (1432 HK): Possible Offer, Potentially Problematic 50% Min Acceptance Condition

By Arun George

  • On 30 October, China Modern Dairy (1117 HK) announced a conditional share purchase agreement to acquire 1.28% of outstanding China Shengmu Organic Milk (1432 HK) shares at HK$0.35 per share. 
  • The SPA is conditional on SAMR and independent CMD shareholder approval. SPA completion will trigger a mandatory conditional cash offer at HK$0.35 per share.
  • Post-Completion, CMD and concert parties will hold a 31.26% stake. The offer is conditional on a 50% minimum acceptance condition, which is problematic as the offer is not particularly attractive.  

Strategic Reviews, Mergers, and Financing Updates: Key Developments in Biopharma, Hospitality

By Special Situation Investments

  • Generation Bio (GBIO) is undergoing a strategic review with potential outcomes including liquidation, reverse merger, or sale, with insiders owning 22%.
  • Sotherly Hotels (SOHOO) is being acquired by two PE firms, with preferred shares trading at a wider spread than common shares.
  • LakeShore Biopharma (LSBCF) signed a definitive privatization agreement at $0.90/share, with closing expected in Q1 2026.

Permira’s Recommended Cash Offer for JTC Plc

By Jesus Rodriguez Aguilar

  • Tight spread: JTC trades 1.7% below Permira’s 1,340p cash offer, implying a modest ~2% annualised return and ~94% market-implied completion probability.
  • Low risk: Fully financed, board-backed, minimal antitrust hurdles; interloper risk negligible after Warburg’s withdrawal.
  • Recommendation: Treat as cash-equivalent carry; lock in gains and redeploy to wider-spread, higher-return opportunities.

TrueCar’s Acquisition by Fair Holdings: Potential Returns, Funding Challenges

By Special Situation Investments

  • TrueCar has signed a definitive agreement to be acquired by Fair Holdings for $2.55 per share in cash.
  • The acquisition deal is 72% funded, with Fair Holdings needing to raise an additional $60 million.
  • TrueCar’s past legal issues are unlikely to impact Fair’s fundraising efforts for the acquisition.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars